PPN/EPN BD tool
254 molecules · EMA / FDA / EMA-only / FDA-only / TR Registered + YDIL · 2018–2026 · 🤝 Combined network: 5,600 contacts (Mustafa + Ufuk)
Last audit: 2026-05-05 (FDA novel approvals through Apr 2026 + EMA CHMP through Dec 2025) · Next audit due: 2026-08-05 · v53
Drag to reorder · Toggle to show/hide
157NPP Assets
🇹🇷 Turkey NPP eligible products — Candidate pool under triage. Click → to commit a product to Action, or ✕ to drop it.
EMA + FDA approved EU EMA-only US FDA-only ★ PPN Partner ★★ 2025–2026 New Orphan designated
🔧 Data Tools · TR data quality: — of — verified Verification chip on every product's expanded view shows last TITCK source & date · PDF button works offline (uses browser print dialog when CDN unreachable)
Clinical
Commercial
TR YDIL Status: On YDIL — import without per-patient TİTCK approval ⭐Fast-track — no additional TİTCK written approval needed (Sheet 2) Individual application — 3-physician council + TİTCK review per patient New — not on YDIL; new TİTCK pathway required ✓ Verified against TİTCK YDIL Excel dated 28/04/2026
🗺 Map — company HQ locations for planning regional roadtrips. Green = you have contacts (Network), amber = PPN partner, blue = target. Click a pin for score, contacts and a one-pager. Clusters group nearby HQs — click to zoom in.
📅 BD event calendar — annual timeline of partnering conventions and scientific congresses. ★★★ primary BD venues (BIO, J.P. Morgan, BIO-Europe, WODC) are the priority targets for meetings; ★★ scientific congresses are for KOL/medical engagement. Past events are dimmed.
📥 Wishlist → Target Companies · upload a molecule wishlist from a territory (Excel/CSV) and get, for every molecule, the candidate manufacturers PPN can approach — each tagged with reference-agency MA fit (EU/FDA/WHO-PQ = COFEPRIS-reliance eligible), entry angle, home country, and Turkish eligibility.
Molecules not yet in our swept pool are flagged so they can be swept and added.
📄
Drop a wishlist file here or tap to choose
Excel (.xlsx/.xls) or CSV — the molecule column is detected automatically
🇲🇽 Mexico — Promising-Tender Target Scanner · high-value molecules across Mexican public tenders — national (federal Compra Consolidada · IMSS-Bienestar / Birmex) and local (state health secretariats · ISSSTE · municipal) — mapped to the companies PPN can actually register.
Registration model differs from the Balkans: Mexico runs on the COFEPRIS equivalence / reliance route (in force 29 Aug 2025) — a product already authorised by a recognised reference authority (ICH members: FDA, EMA, PMDA, Health Canada, Swissmedic…, WHO-listed authorities, or WHO-PQ for generics) qualifies for an abbreviated ~45-business-day review. PPN acts as the Mexican titular de registro + local importer. So targets are ranked by registration fit — does the holder carry a qualifying reference-agency MA — not by an EU-register cascade.
🌍→🇲🇽 Supply-partner targets: PPN brings a reference-agency-approved manufacturer (EU MA / FDA / WHO-PQ) into Mexico under the COFEPRIS equivalence route, acting as titular de registro + importer — the target is any globally-approved maker without a Mexican entity, especially EU-MA holders whose product meets the equivalence criteria. Turkish manufacturers are the fast-access lane (TITCK is an ICH regulatory member since 2020), but not the only scope. See 🎯 Target Opportunities for the molecule-by-molecule addressable prize and entry angle.
📋 BD Board — one consolidated pipeline across territories: 🇹🇷🇷🇺🇩🇿 Turkey · Russia · Algeria and 🇲🇰 Non-EU Balkans cards share the same stage columns (Balkan stages mapped: Target→Not started · Contacted→Outreach · In talks→In discussion · Agreement→Negotiating · Active partner→Signed · Passed→Lost). A company can sit at different stages per territory — each territory gets its own card. Add a company below (lands in Not started with you as lead). Red border = stalled 21+ days.
📊 Progress — one consolidated funnel across territories (🇹🇷🇷🇺🇩🇿 Turkey · Russia · Algeria + 🇲🇰 Balkans): how we're collectively moving companies through the stages, who leads what, and what needs attention this week.
⚡ Action Center — your single place to act. One priority-ranked stream: urgent nudges (overdue, stalled, waiting — tagged NUDGE) interleaved by urgency with auto-drafted multi-step plans (tagged PLAN) across the pipeline, leads, and Balkans, refreshed weekly from your intel, board stage, and network. ✓ done / 💤 snooze as you go. Distinct from the Progress funnel.
✅ Signed Deals — PPN's live book of business: every signed project across all territories, by current status. Data is served live from Supabase, so status changes appear here without a redeploy. Turkish-manufacturer outbound deals are grouped separately at the bottom per prioritization.
🤝 Network — companies where at least one of the three of you has a contact. Ranked by company score (unscored companies sink to the bottom). Click a row for products; download an editable Word one-pager.
🎯 Targets — companies you have no contact at yet. Same scoring; upload your LinkedIn connections to move companies into Network as your reach grows.
🇲🇰 Non-EU Balkans — Target Scanner · North Macedonia → Albania → Kosovo. Separate operating model from the Turkey NPP business: PPN acts as Marketing Authorization Holder (PPM) or as distributor. Targets are B2B dossier / license-and-supply houses (Adalvo, Synthon type) and EU manufacturers holding their own EU MAs willing to share marketed CPPs. Registration cascade: register in NMK first → obtain marketed CPP → file in AL & XK.
Products you've dropped from active pursuit. Click Restore to move back to Pipeline.
build 2026-06-14